Versican vs versikine: tolerance vs attack.

@article{Schmitt2016VersicanVV,
  title={Versican vs versikine: tolerance vs attack.},
  author={Michael Schmitt},
  journal={Blood},
  year={2016},
  volume={128 5},
  pages={612-3}
}
that FBXO11 regulates the stability of BCL6 but also raises some important questions. In this regard, the previously described role of phosphorylation in BCR signaling linked degradation ofBCL6, but data presented in this article contradict the original findings by Duan et al, which suggest that BCL6 degradation by FBXO11 does not require phosphorylation and may occur in the absence of BCR signaling. In addition, the BCL6 degron has not been identified and thus there is not yet a full… CONTINUE READING